Wordt geladen...
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies
Pancreatic cancer remains largely an incurable disease necessitating the development of novel therapeutic approaches. Adoptive immunotherapy using chimeric antigen receptor (CAR)-transduced T cells represents an alternative treatment with curative potential. We present an overview of the engineering...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Landes Bioscience
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4108460/ https://ncbi.nlm.nih.gov/pubmed/25083334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.29194 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|